Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06162026 · ClinicalTrials.gov registry record · NA
Cognitive Screening Made Easy for PCPs - R33 Phase
A NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Texas at Austin.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06162026: Active NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Texas at Austin.
NCT06162026 is a NA study of Cognitive Impairment and Cognitive Decline that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 500 participants, below the 661-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06162026, a NA study of Cognitive Impairment and Cognitive Decline, is active but no longer recruiting, sponsored by University of Texas at Austin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.
Primary Outcome
Combination of symbol matching and voice tasks, which generates a cognitive performance score ranging from 0 to 1 (high scores mean higher likelihood of cognitive impairment)
Conditions Studied
Interventions
- BEHAVIORAL RACS app
Study Locations (1)
Texas
- Family Wellness Clinic - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What the registry record for NCT06162026 still lists
NCT06162026 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 661-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (24% lower).
The record links to 3 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which RACS app is the first listed.
NCT06162026 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06162026 about?
NCT06162026 is a clinical study titled "Cognitive Screening Made Easy for PCPs - R33 Phase". This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will b...
What is the current status of trial NCT06162026?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-02-02. Estimated completion is 2027-04-30.
What conditions does trial NCT06162026 study?
This clinical trial studies the following conditions: Cognitive Impairment, Cognitive Decline, Dementia, Mild.
What interventions are being tested in trial NCT06162026?
The interventions under investigation include: RACS app (BEHAVIORAL).
Who is sponsoring clinical trial NCT06162026?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06162026 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06162026's enrollment target sits among peer trials
500 9th of 105 higher than 97 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI